Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-18-051419)

Filing Details

Accession Number:: 0001209191-18-051419
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-09-18 16:03:16
Reporting Period:: 2018-09-14

Accepted Time:: 2018-09-18 16:03:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1337553	Aerie Pharmaceuticals Inc	AERI	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1252014	J Richard Rubino	C/O Aerie Pharmaceuticals, Inc. 4301 Emperor Blvd., Suite 400 Durham NC 27703	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-09-14	2	$60.00	383,736	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

These shares, along with the 34,512 shares sold by the reporting person on September 13, 2018 (as reported on the Form 4 filed on September 14, 2018), were sold pursuant to the reporting person's Rule 10b5-1 plan.